# | Title | Journal | Year | Citations |
---|
1 | Design and validation of a histological scoring system for nonalcoholic fatty liver disease | Hepatology | 2005 | 8,518 |
2 | Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance test | Liver International | 2004 | 7,546 |
3 | Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes | Hepatology | 2016 | 7,346 |
4 | Management of hepatocellular carcinoma: An update | Hepatology | 2011 | 7,111 |
5 | EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma | Journal of Hepatology | 2018 | 6,153 |
6 | The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic | Nature Reviews Gastroenterology and Hepatology | 2014 | 5,773 |
7 | Management of hepatocellular carcinoma | Hepatology | 2005 | 5,426 |
8 | EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma | Journal of Hepatology | 2012 | 5,214 |
9 | Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis | Gastroenterology | 2007 | 4,828 |
10 | The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases | Hepatology | 2018 | 4,738 |
11 | Histological grading and staging of chronic hepatitis | Journal of Hepatology | 1995 | 4,685 |
12 | Functional Bowel Disorders | Gastroenterology | 2006 | 4,197 |
13 | A model to predict survival in patients with end-stage liver disease | Hepatology | 2001 | 4,112 |
14 | Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review | Gastroenterology | 2012 | 4,013 |
15 | Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference | Journal of Hepatology | 2001 | 3,959 |
16 | EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection | Journal of Hepatology | 2017 | 3,803 |
17 | Steatohepatitis: A tale of two “hits”? | Gastroenterology | 1998 | 3,644 |
18 | An algorithm for the grading of activity in chronic hepatitis C | Hepatology | 1996 | 3,593 |
19 | Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention | Nature Reviews Gastroenterology and Hepatology | 2018 | 3,487 |
20 | A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C | Hepatology | 2003 | 3,455 |
21 | EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease | Journal of Hepatology | 2016 | 3,403 |
22 | Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification | Seminars in Liver Disease | 1999 | 3,350 |
23 | Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection | Hepatology | 2006 | 3,343 |
24 | Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis | Hepatology | 1981 | 3,336 |
25 | Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity | Hepatology | 2004 | 3,250 |
26 | Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma | Seminars in Liver Disease | 2010 | 3,250 |
27 | Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions | American Journal of Gastroenterology | 1999 | 3,233 |
28 | The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus | American Journal of Gastroenterology | 2006 | 3,207 |
29 | Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics | Nature Reviews Gastroenterology and Hepatology | 2017 | 3,192 |
30 | Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases | Hepatology | 2018 | 3,096 |
31 | Development of a Crohn's Disease Activity Index | Gastroenterology | 1976 | 3,013 |
32 | Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity☆, ☆☆ | Gastroenterology | 1999 | 3,005 |
33 | The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association | Hepatology | 2012 | 2,935 |
34 | AASLD guidelines for the treatment of hepatocellular carcinoma | Hepatology | 2018 | 2,932 |
35 | Biology of Incretins: GLP-1 and GIP | Gastroenterology | 2007 | 2,918 |
36 | Long-term Expansion of Epithelial Organoids From Human Colon, Adenoma, Adenocarcinoma, and Barrett's Epithelium | Gastroenterology | 2011 | 2,835 |
37 | EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection | Journal of Hepatology | 2012 | 2,784 |
38 | Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma | Gastroenterology | 2012 | 2,753 |
39 | International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis | Journal of Hepatology | 1999 | 2,681 |
40 | Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences | Gastroenterology | 2004 | 2,658 |
41 | Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival | Hepatology | 2003 | 2,646 |
42 | Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance | Hepatology | 2018 | 2,620 |
43 | Diagnosis, management, and treatment of hepatitis C: An update | Hepatology | 2009 | 2,610 |
44 | Expanding consensus in portal hypertension | Journal of Hepatology | 2015 | 2,604 |
45 | Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults | Alimentary Pharmacology and Therapeutics | 2011 | 2,569 |
46 | The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study | Gastroenterology | 2005 | 2,544 |
47 | Chronic hepatitis B: Update 2009 | Hepatology | 2009 | 2,506 |
48 | MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer | Gastroenterology | 2007 | 2,499 |
49 | A global view of hepatocellular carcinoma: trends, risk, prevention and management | Nature Reviews Gastroenterology and Hepatology | 2019 | 2,482 |
50 | A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts | Hepatology | 2000 | 2,466 |
51 | Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies | Journal of Hepatology | 2006 | 2,459 |
52 | Classification of chronic hepatitis: Diagnosis, grading and staging | Hepatology | 1994 | 2,456 |
53 | The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD | Hepatology | 2007 | 2,448 |
54 | Chronic hepatitis B | Hepatology | 2007 | 2,422 |
55 | Mechanisms of Hepatic Fibrogenesis | Gastroenterology | 2008 | 2,381 |
56 | Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas | Gastroenterology | 1994 | 2,329 |
57 | Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma | Hepatology | 2002 | 2,322 |
58 | Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome | Gastroenterology | 2012 | 2,287 |
59 | Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome | Hepatology | 2003 | 2,276 |
60 | Evidence for Gastrointestinal Infection of SARS-CoV-2 | Gastroenterology | 2020 | 2,222 |
61 | Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C | Gastroenterology | 2005 | 2,216 |
62 | Model for end-stage liver disease (MELD) and allocation of donor livers | Gastroenterology | 2003 | 2,212 |
63 | Acute-on-Chronic Liver Failure Is a Distinct Syndrome That Develops in Patients With Acute Decompensation of Cirrhosis | Gastroenterology | 2013 | 2,211 |
64 | The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide | Journal of Hepatology | 2006 | 2,205 |
65 | Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures | Journal of Viral Hepatitis | 2004 | 2,202 |
66 | Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease | Gastroenterology | 2015 | 2,200 |
67 | Primary liver cancer: Worldwide incidence and trends | Gastroenterology | 2004 | 2,193 |
68 | Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C | Hepatology | 1994 | 2,184 |
69 | A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement | Journal of Hepatology | 2020 | 2,171 |
70 | Hepatocellular carcinoma in cirrhosis: Incidence and risk factors | Gastroenterology | 2004 | 2,168 |
71 | Burden of liver diseases in the world | Journal of Hepatology | 2019 | 2,125 |
72 | Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalence | Hepatology | 2013 | 2,118 |
73 | Nonalcoholic fatty liver disease: From steatosis to cirrhosis | Hepatology | 2006 | 2,116 |
74 | A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice | Gastroenterology | 1990 | 2,091 |
75 | Review article: the role of butyrate on colonic function | Alimentary Pharmacology and Therapeutics | 2008 | 2,048 |
76 | International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas | Pancreatology | 2012 | 2,043 |
77 | Long-term follow-up of patients with NAFLD and elevated liver enzymes | Hepatology | 2006 | 2,038 |
78 | NAFLD: A multisystem disease | Journal of Hepatology | 2015 | 2,037 |
79 | Colorectal cancer screening and surveillance: Clinical guidelines and rationale?Update based on new evidence | Gastroenterology | 2003 | 2,016 |
80 | Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology | Gastroenterology | 2008 | 2,002 |
81 | Adalimumab for Maintenance of Clinical Response and Remission in Patients With Crohn’s Disease: The CHARM Trial | Gastroenterology | 2007 | 1,986 |
82 | Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis | Gastroenterology | 2017 | 1,983 |
83 | Early indicators of prognosis in fulminant hepatic failure | Gastroenterology | 1989 | 1,981 |
84 | Inflammatory bowel disease: Etiology and pathogenesis | Gastroenterology | 1998 | 1,955 |
85 | Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival | Hepatology | 2001 | 1,931 |
86 | Characterization of the Human Colon Carcinoma Cell Line (Caco-2) as a Model System for Intestinal Epithelial Permeability | Gastroenterology | 1989 | 1,916 |
87 | Bowel Disorders | Gastroenterology | 2016 | 1,912 |
88 | Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update | Hepatology International | 2016 | 1,908 |
89 | Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota | Gastroenterology | 1997 | 1,898 |
90 | The Functional Gastrointestinal Disorders and the Rome III Process | Gastroenterology | 2006 | 1,891 |
91 | Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection | American Journal of Gastroenterology | 2002 | 1,878 |
92 | Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: Resection versus transplantation | Hepatology | 1999 | 1,869 |
93 | Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis | Hepatology | 2010 | 1,857 |
94 | Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study | Gastroenterology | 2011 | 1,856 |
95 | Gluten, major histocompatibility complex, and the small intestine | Gastroenterology | 1992 | 1,853 |
96 | Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities | Gastroenterology | 2001 | 1,846 |
97 | MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease | Gastroenterology | 2020 | 1,840 |
98 | Mechanisms of hepatic stellate cell activation | Nature Reviews Gastroenterology and Hepatology | 2017 | 1,821 |
99 | International Consensus Guidelines for Management of Intraductal Papillary Mucinous Neoplasms and Mucinous Cystic Neoplasms of the Pancreas | Pancreatology | 2006 | 1,805 |
100 | Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference | Hepatology | 2003 | 1,791 |